Informationen:
Fehler:
Stichworte
Rhinitis, allergische ×
- Klinische Studie [Dokumenttyp] (14)
- Atmungsfunktionstests (4)
- Vitalzeichen (4)
- Visuelle Analogskala (4)
- Behandlungsbedürftigkeit, Begutachtung (4)
- Urinuntersuchung (3)
- Electrocardiogram (ECG) (3)
- Laboratorien (3)
- Trial screening (2)
- Pharmakogenetik (1)
- Schwangerschaft (1)
- Rhinitis (1)
- Asthma (1)
- Arzneimittel, Prüf- (1)
- Kind (1)
- Symptombewertung (1)
- Adverse event (1)
- Concomitant Medication (1)
- End of Study (1)
- Demographie (1)
- Dermatologie (1)
- Allergie und Immunologie (1)
- Verlaufsstudien (1)
Inhaltsverzeichnis
Ausgewählte Datenmodelle
Sie müssen eingeloggt sein, um mehrere Datenmodelle auszuwählen und diese herunterzuladen oder zu analysieren.
15 Suchergebnisse.
Itemgruppen: Inclusion Criteria, Exclusion Criteria
Itemgruppen: Total Nasal Symptom Scores, VAS, Pharmacogenetic Research Consent, Pharmacogenetic Research Withdrawal of Consent
Itemgruppen: Concomitant Medication, 12-Lead ECG/ Holter/ Telemetry ECG, ECG Abnormalities, Vital Signs, Local Laboratory, Local Laboratory - Haematology , Local Laboratory - Clinical Chemistry, Urinalysis - Local, Urinalysis - Local: Dipstick Details, Urinalysis - Local: Microscopy Details, Pulmonary Function Tests, Nasal Airflow Resistance, Nasal Inspection
Itemgruppen: Logs and Repeats - Date of visit/assessment, Logs and Repeats - Adverse Event/Concomitant Medication/Repeat Assessment Check Questions, Non-Serious Adverse Event, Serious Adverse Event - Type of Report, Serious Adverse Event - Randomisation, Serious Adverse Event, Serious Adverse Event - Serious, Serious Adverse Event - Relevant Concomitant/Treatment Medications, Serious Adverse Event - Relevant Medical Conditions/Risk Factors, Serious Adverse Event - Relevant Diagnostic Results, Serious Adverse Event - Investigational Products, Serious Adverse Event - General Narrative Comments, Serious Adverse Event - No clinical
Itemgruppen: Pregnancy Information, Status of Treatment Blind, Study Conclusion
Itemgruppen: Date of Visit, 12-Lead ECG/ Holter/ Telemetry ECG, Vital Signs, Pulmonary Function Tests, Local Laboratory - Haematology, Local Laboratory - Haematology , Local Laboratory - Clinical Chemistry, Local Laboratory - Clinical Chemistry, Urinalysis - Local, Urinalysis - Local: Dipstick Details, Urinalysis - Local: Microscopy Details
Itemgruppen: Inform Screening, Inform Enrolment, Date of Visit, Demography, 12-Lead ECG, Vital Signs - Measurement 1, Vital Signs - Measurement 2 and 3 , Local Laboratory - Haematology, Local Laboratory - Haematology , Local Laboratory - Clinical Chemistry, Local Laboratory - Clinical Chemistry, Urinalysis - Local, Urinalysis - Local: Dipstick Details, Urinalysis - Local: Microscopy Details, Nasal Inspection
Itemgruppen: Date of Visit, Challenge Date and Time (0-4 Hr), Pulmonary Function Tests - Challenge Date and Time, Pulmonary Function Tests - Start of Challenge, Pulmonary Function Tests - 1 hr Post Challenge Start, Pulmonary Function Tests - 2 hr Post Challenge Start , Pulmonary Function Tests - 3 hr Post Challenge Start, Pulmonary Function Tests - 4 hr Post Challenge Start , Nasal Allergen Challenge - Challenge Date and Time, Nasal Allergen Challenge - Start of Challenge, Nasal Allergen Challenge, Nasal Airflow Resistance - Challenge Date and Time, Nasal Airflow Resistance - 30 Min Post-Challenge, Nasal Airflow Resistance, Nasal Secretions - Challenge Date and Time, Nasal Secretions - Start of Challenge, Nasal Secretions, VAS - Challenge Date and Time, VAS - Dosing Date and Time, VAS - Start of Challenge, VAS
Itemgruppen: Challenge Date and Time (Visit 1, 3, 5), Pulmonary Function Tests - Challenge Date and Time (Visit 1, 3, 5), Pulmonary Function Tests - Dosing Date and Time (Visit 1, 3, 5), Pulmonary Function Tests - Start of Challenge (Visit 1, 3, 5), Pulmonary Function Tests - 1 hr Post Challenge Start (Visit 1, 3, 5), Pulmonary Function Tests - 2 hr Post Challenge Start (Visit 1, 3, 5), Pulmonary Function Tests - 3 hr Post Challenge Start (Visit 1, 3, 5), Pulmonary Function Tests - 4 hr Post Challenge Start (Visit 1, 3, 5), Pulmonary Function Tests - 5 hr Post Challenge Start (Visit 1, 3, 5), Pulmonary Function Tests - 6 hr Post Challenge Start (Visit 1, 3, 5), Nasal Allergen Challenge - Challenge Date and Time (Visit 1, 3, 5), Nasal Allergen Challenge - Dosing Date and Time (Visit 1, 3, 5), Nasal Allergen Challenge - Start of Challenge (Visit 1, 3, 5), Nasal Allergen Challenge (Visit 1, 3, 5), Nasal Airflow Resistance - Challenge Date and Time (Visit 1, 3, 5), Nasal Airflow Resistance - 30 Min Post-Challenge (Visit 1, 3, 5), Nasal Airflow Resistance (Visit 1, 3, 5), Nasal Secretions - Challenge Date and Time (Visit 1, 3, 5), Nasal Secretions - Dosing Date and Time (Visit 1, 3, 5), Nasal Secretions - Start of Challenge (Visit 1, 3, 5), Nasal Secretions (Visit 1, 3, 5), VAS - Challenge Date and Time (Visit 1, 3, 5), VAS - Dosing Date and Time (Visit 1, 3, 5), VAS - Start of Challenge (Visit 1, 3, 5), VAS (Visit 1, 3, 5)
Itemgruppen: Date of Visit, Randomisation Number (Vsit 1), Vital Signs - Challenge Date and Time (Visit 1, 3, 5), Vital Signs - Start of Challenge (Visit 1, 3, 5), Nasal Inspection (Visit 1, 3, 5), Challenge Date and Time - Challenge (0 - 6 Hr) (Visit 1, 3, 5), Investigational Product (Dose) - Challenge Date and Time (Visit 1, 3, 5), Investigational Product - Date/time of dose (Visit 1, 3, 5), Investigational Product - Treatment Confirmation (Visit 1, 3, 5)
Itemgruppen: Eligibility Question, Subject Identification
Itemgruppen: Challenge Date and Time, Pulmonary Function Tests - Challenge Date and Time, Pulmonary Function Tests - Start of Challenge, Pulmonary Function Tests - 1 hr Post Challenge Start, Pulmonary Function Tests - 2 hr Post Challenge Start , Nasal Allergen Challenge - Challenge Date and Time, Nasal Allergen Challenge - Pre-Dose, Nasal Allergen Challenge - 20 Min; 40 Min; 1 Hr; 1 Hr 20 Min; 1 Hr 40 Min; 2 Hr, Nasal Airflow Resistance - Challenge Date and Time, Nasal Airflow Resistance - 30 Min Post-Challenge, Nasal Airflow Resistance - 1 Hr 30 Min Post Challenge, Nasal Secretions - Challenge Date and Time, Nasal Secretions - Start of Challenge, Nasal Secretions - 1 Hr and 2 Hr Post-Challenge Start , VAS - Challenge Date and Time, VAS - Pre-Dose, VAS - 20 Min; 40 Min; 1 Hr; 1 Hr 20 Min; 1 Hr 40 Min; 2 Hr